Firms
Theme

NMR

Nomura Holdings, Inc · NYSE

News

3 latest

Zacks Investment Research

NMR vs. TW: Which Stock Is the Better Value Option?

In a comparison of two Financial - Investment Bank stocks, Nomura Holdings (NMR) emerges as the more attractive value investment option compared to Tradeweb Markets (TW). NMR has a superior Zacks Rank of #2 (Buy) versus TW's #3 (Hold), indicating stronger earnings estimate revisions.

Zacks Investment Research

Nomura (NMR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Nomura Holdings (NMR) has formed a hammer chart pattern after an 8.3% decline over four weeks, suggesting a potential trend reversal. The technical signal is supported by fundamental strength, with Wall Street analysts raising earnings estimates by 5.4% over the last 30 days. NMR holds a Zacks Rank #2 (Buy) rating, placing it in the top 20% of stocks based on earnings estimate revision trends.

Zacks Investment Research

NMR or TW: Which Is the Better Value Stock Right Now?

A comparison of two Financial - Investment Bank sector stocks reveals that Nomura Holdings (NMR) is the superior value investment option compared to Tradeweb Markets (TW). NMR has a higher Zacks Rank (#2 Buy vs #3 Hold), more attractive valuation metrics including a lower forward P/E ratio (10.22 vs 25.25), better PEG ratio (1.13 vs 1.66), and lower P/B ratio (1.17 vs 3.21), earning a Value grade of B compared to TW's F grade.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $NMR · 0 threads

Sign in to post on $NMR

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev